Cargando…

Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma

BACKGROUND: MYC is a key transcription factor involved in central cellular processes such as regulation of the cell cycle, histone acetylation and ribosomal biogenesis. It is overexpressed in the majority of human tumors including aggressive B-cell lymphoma. Especially Burkitt lymphoma (BL) is a hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seitz, Volkhard, Butzhammer, Peter, Hirsch, Burkhard, Hecht, Jochen, Gütgemann, Ines, Ehlers, Anke, Lenze, Dido, Oker, Elisabeth, Sommerfeld, Anke, von der Wall, Edda, König, Christoph, Zinser, Christian, Spang, Rainer, Hummel, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213110/ https://www.ncbi.nlm.nih.gov/pubmed/22102868 http://dx.doi.org/10.1371/journal.pone.0026837

Ejemplares similares

DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations
por: Akpa, Chidimma Agatha, et al.
Publicado: (2019)

Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
por: Kleo, Karsten, et al.
Publicado: (2019)

A new method to prevent carry-over contaminations in two-step PCR NGS library preparations
por: Seitz, Volkhard, et al.
Publicado: (2015)

Tuberous sclerosis complex is required for tumor maintenance in MYC‐driven Burkitt's lymphoma
por: Hartleben, Götz, et al.
Publicado: (2018)

Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
por: De Falco, Giulia, et al.
Publicado: (2015)

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patients
por: Vollbrecht, Claudia, et al.
Publicado: (2018)

Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles
por: Klopfleisch, Robert, et al.
Publicado: (2010)

Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma
por: Onnis, Anna, et al.
Publicado: (2010)

Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling
por: Spender, Lindsay C, et al.
Publicado: (2014)

Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases
por: Mundo, Lucia, et al.
Publicado: (2019)

Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
por: Poole, Candace J., et al.
Publicado: (2018)

Dissecting the molecular pathogenisis of Burkitt lymphoma
por: Kube, D, et al.
Publicado: (2009)

The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS
por: Grygalewicz, Beata, et al.
Publicado: (2018)

MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas
por: Aquino, Gabriella, et al.
Publicado: (2013)

Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature
por: Woroniecka, Renata, et al.
Publicado: (2022)

Integrative genomic analysis focused on cell cycle genes for MYC-driven aggressive mature B-cell lymphoma
por: Yamashita, Takahisa, et al.
Publicado: (2020)

The CT-Element of The C-Myc Gene Does Not Predispose to Chromosomal Breakpoints in Burkitt'S Lymphoma
por: Weber, Achim, et al.
Publicado: (2006)

Genetic features of precursor B‐cell phenotype Burkitt leukemia with IGH‐ MYC rearrangement
por: Yoshida, Masanori, et al.
Publicado: (2021)

Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma
por: López, Cristina, et al.
Publicado: (2019)

Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
por: Vance, Gail H, et al.
Publicado: (2023)

Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model
por: Akpa, Chidimma Agatha, et al.
Publicado: (2020)

Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells
por: Sander, Sandrine, et al.
Publicado: (2012)

How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
por: Allday, Martin J.
Publicado: (2009)

Molecular mechanism of c‐Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma
por: Li, Ting, et al.
Publicado: (2020)

Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
por: Ayers, LW, et al.
Publicado: (2009)

Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation
por: Stasevich, Ekaterina Mikhailovna, et al.
Publicado: (2022)

Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression
por: Suk, Fat-Moon, et al.
Publicado: (2015)

Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes
por: Klopfleisch, Robert, et al.
Publicado: (2012)

Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL
por: Seitz, V., et al.
Publicado: (2020)

DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt’s lymphoma
por: Poole, Candace J., et al.
Publicado: (2017)

JNK/AP1 Pathway Regulates MYC Expression and BCR Signaling through Ig Enhancers in Burkitt Lymphoma Cells
por: Ding, Xiaoling, et al.
Publicado: (2020)

Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia
por: Möker, Paula, et al.
Publicado: (2022)

Pediatric in-hospital emergencies: real life experiences, previous training and the need for training among physicians and nurses
por: Lehmann, Ronny, et al.
Publicado: (2019)

Molecular and Cytogenetic Studies in a Child with Burkitt Lymphoma and Ataxia-Telangiectasia Syndrome Harboring MYC Overexpression and Partial Trisomy 8
por: De Souza, Mariana T., et al.
Publicado: (2018)

Interfering with Bacterial Quorum Sensing
por: Reuter, Kerstin, et al.
Publicado: (2016)

Understanding and Treating Unwanted Trauma Memories in Posttraumatic Stress Disorder
por: Ehlers, Anke
Publicado: (2010)

Burkitt Lymphoma in the Mouse
por: Kovalchuk, Alexander L., et al.
Publicado: (2000)

Burkitt Lymphoma of the Duodenum
por: Matsueda, Katsunori, et al.
Publicado: (2017)

Burkitt's lymphoma of the mandible
por: Kuo, Ying-Shiung, et al.
Publicado: (2017)

MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma
por: Kwanhian, Wiyada, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dlnt0q9i4ep36fe56qqhm4vrmc